Abound Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.81K | Buy |
87
+35
| +67% | +$2.74K | ﹤0.01% | 512 |
|
|
2025
Q1 | $3.77K | Sell |
52
-54
| -51% | -$3.91K | ﹤0.01% | 594 |
|
|
2024
Q4 | $7.86K | Buy |
106
+2
| +2% | +$148 | ﹤0.01% | 438 |
|
|
2024
Q3 | $6.86K | Sell |
104
-12
| -10% | -$792 | ﹤0.01% | 480 |
|
|
2024
Q2 | $10.7K | Hold |
116
| – | – | ﹤0.01% | 356 |
|
|
2024
Q1 | $11.1K | Buy |
116
+1
| +0.9% | +$95 | ﹤0.01% | 352 |
|
|
2023
Q4 | $8.77K | Sell |
115
-14
| -11% | -$1.07K | ﹤0.01% | 395 |
|
|
2023
Q3 | $8.94K | Sell |
129
-6
| -4% | -$416 | ﹤0.01% | 353 |
|
|
2023
Q2 | $12.7K | Buy |
135
+40
| +42% | +$3.77K | 0.01% | 298 |
|
|
2023
Q1 | $7.86K | Buy |
95
+44
| +86% | +$3.64K | ﹤0.01% | 321 |
|
|
2022
Q4 | $3.81K | Hold |
51
| – | – | ﹤0.01% | 400 |
|
|
2022
Q3 | $4.22K | Buy |
+51
| New | +$4.22K | ﹤0.01% | 381 |
|